Thermo Fisher to Acquire Brammer Bio

Posted by ISPE Boston
On April 24, 2019

Thermo Fisher Scientific has announced it will acquire Brammer Bio for approximately $1.7 billion in cash. Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO) with nearly 600 employees at primary locations in Massachusetts and Florida. Brammer Bio is on track to deliver $250 million of revenue in 2019 and expects to […]

Rivalries Created…Heroes Crowned…Hearts Broken…

Posted by Michael Degirolamo
On April 23, 2019

The Chapter’s Young Professionals held a bowling and networking event on April 4th when over 25 biotech and pharma professionals of all ages and backgrounds gathered at The Flatbread Company in Somerville to socialize, eat some amazing pizza and bowl their hearts out! The event began with networking over a few drinks and wood-fired pizza […]

Spring Conference Showcases “The Culture of Exceptional Project Management”

Posted by Jesse McLaughlin
On April 18, 2019

From his experience with a tragic, shipboard accident while at Mass Maritime Academy, to his recent project successes on the buildout at Pfizer in Andover, Gil Stevens, Senior Director of Engineering at Pfizer, opened the Chapter’s half-day Spring Conference with lessons learned about the culture of exceptional project management and set the tone for a […]

Students Shine at Poster Competition

Posted by Jesse McLaughlin
On April 17, 2019

One neat addition to the Spring Conference was the Student Poster Competition. We had four submissions by students from Northeastern University, University of New Hampshire and Middlesex Community College describing research they had conducted. The winners were James Sinoimeri from Northeastern (Hypoxia- Inducing Cryogels for Preclinical anticancer Drug Screening) and Nate Cunningham from UNH (Printable […]

Past President John Spohn on Winning the Chapter’s Highest Honor

Posted by John Spohn
On April 11, 2019

Yesterday I attended the inaugural Spring Conference of the Boston Area Chapter and I rate it an unqualified success. The conference on the Culture of Exceptional Project Management was indeed a perfect example thereof. Hats off to Howard Sneider and the committee that hit a home run, in their first at-bat. And the final networking […]

Chapter Member Anniversaries: March 2019

Posted by ISPE Boston
On April 5, 2019

Please congratulate the following members celebrating milestone anniversaries in March 2019. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Saboo Aghababayan, MS, MBA, Genzyme Corp Richard Francis Caires, Jr., Shire HGT Ronald C. Case Dr. Charles L. Cooney Robert C. Davis, Process Control Solutions Edward F. […]

Welcome New Members!

Posted by ISPE Boston
On April 5, 2019

We would like to introduce the Members who joined ISPE in March 2019, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Ironwood to Focus on GI Diseases, Spins Off Cyclerion Therapeutics

Posted by ISPE Boston
On April 4, 2019

Ironwood Pharmaceuticals, a GI-focused healthcare company, has announced that it has completed the tax-free spin-off of its soluble guanylate cyclase (sGC) business, Cyclerion Therapeutics. Ironwood is executing on its strategy to drive growth as a GI-focused company, building upon its commercial success with Linzess and advancing its late-stage, first-in-category development candidates including IW-3718 for the […]

Ironwood Spin-Off Cyclerion Launches as Clinical-Stage Biopharm

Posted by ISPE Boston
On April 4, 2019

Cyclerion Therapeutics has announced its launch as an independent, publicly traded clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion will trade on the Nasdaq Global Market, commencing today, under the ticker symbol “CYCN.” “We are excited to unleash […]

Novartis Adds Anti-Inflammatory Programs with Acquisition of IFM Tre

Posted by ISPE Boston
On April 3, 2019

Pharmaceutical giant Novartis has announced the planned acquisition of Boston-based start-up IFM Tre, a subsidiary of IFM Therapeutics focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome. The acquisition will give Novartis full rights to IFM Tre’s portfolio of NLRP3 inhibitors. The NLRP3 (nucleotide-binding domain, leucine-rich repeat-containing receptor pyrin domain containing 3) pathway plays a […]

Page 3 of 37‹1 234 5 ›»

Blog